Carolien Zeetsen

145 References R Jovanovski, D., Erb, S., & Zakzanis, K.K. (2005). Neurocognitive deficits in cocaine users: a quantitative review of the evidence. Journal of Clinical and Experimental Neuropsychology, 27 (2), 189–204. https://doi.org/10.1080/13803390490515694 Julayanont, P., Brousseau, M., Chertkow, H., Phillips, N., & Nasreddine, Z.S. (2014, Apr). Montreal Cognitive Assessment Memory Index Score (MoCA–MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer’s disease. Journal of the American Geriatrics Society, 62 (4), 679–684. https://doi.org/10.1111/jgs.12742 Julayanont, P., Phillips, N.A., Chertkow, H., & Nasreddine, Z.S. (2013). The Montreal Cognitive Assessment (MoCA): concept and clinical review. In A.J. Larner (Ed.), Cognitive screening instruments: a practical approach (pp. 111–152). London, United Kingdom, Springer. Kamal, R.M., van Noorden, M.S., Wannet, W., Beurmanjer, H., Dijkstra, B.A.G., & Schellekens, A.F.A. (2017). Pharmacological treatment in g–Hydroxybutyrate (GHB) and g–Butyrolactone (GBL) dependence: detoxification and relapse prevention. CNS Drugs, 31 , 51–64. https://doi.org/10.1007/s40263-016- 0402-z Kolakowsky–Hayner, S.A., Wright, J., & Bellon, K. (2012). A brief overview of the Patient Competency Rating Scale: updates and additions to the COMBI. Journal of Head Trauma Rehabilitation, 27 (1), 83–85. https://doi.org/10.1097/HTR.0b013e31823645db Kopecek, M., Bezdicek, O., Sulc, Z., Lukavsky, J., & Stepankova, H. (2017). Montreal Cognitive Assessment and Mini–Mental State Examination reliable change indices in healthy older adults. International Journal of Geriatric Psychiatry, 32 (8), 868–875. https://doi.org/10.1002/gps.4539 Kopecek, M., Stepankova, H., Lukavsky, J., Ripova, D., Nikolai, T., & Bezdicek, O. (2017). Montreal Cognitive Assessment (MoCA): normative data for old and very old Czech adults. Applied Neuropsychology: Adult, 24 (1), 23–29. https://doi.org/10.1080/23279095.2015.1065261 Kopelman, M.D. (2002). Disorders of memory. Brain, 125 , 2152–2190. https://doi.org/10.1093/brain/awf229 Kroll, S.L., Nikolic, E., Bieri, F., Soyka, M., Boumgartner, M.R., & Quednow, B.B. (2018). Cognitive and socio– cognitive functioning of chronic non–medical prescription opioid users. Psychopharmacology, 235 , 3451–3464. https://doi.org/10.1007/s00213-18-5060-z Lakens, D. (2013). Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t –tests and ANOVAs. Frontiers in Psychology, 4 (Article 863), 1–12. https://doi.org/10.3389/ fpsyg.2013.00863 Larouche, E., Tremblay, M.P., Potvin, O., Laforest, S., Bergeron, D., Laforce, R., Monetta, L., Boucher, L., Tremplay, P., Belleville, S., Lorrain, D., Gagnon, J.F., Gosselin, N., Castellano, C.A., Cunnane, S.C., Macoir, J., & Hudon, C. (2016). Normative data for the Montreal Cognitive Assessment in middle– aged and elderly Quebec–French people. Archives of Clinical Neuropsychology, 31 (7), 819–826. https://doi.org/10.1093/arclin/acw076 Laudet, A.B., Savage, R., & Mahmood, D. (2002). Pathways to long–term recovery: a preliminary investigation. Journal of Psychoactive Drugs, 34 (3), 305–311. https://doi.org/10.1080/02791072.2 002.10399968